- Home
- NKTR vs NBTB Comparison
NKTR vs NBTB Comparison
Compare NKTR & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NKTR | NBTB |
|---|---|---|
| Founded | 1990 | 1856 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 1996 | 1995 |
Fundamental Metrics
Financial Performance| Metric | NKTR | NBTB |
|---|---|---|
| Price | $73.12 | $42.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $130.00 | $52.00 |
| AVG Volume (30 Days) | ★ 782.4K | 197.7K |
| Earning Date | 03-12-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.53% |
| EPS Growth | N/A | ★ 12.12 |
| EPS | N/A | ★ 3.33 |
| Revenue | ★ $307,711,000.00 | $182,952,000.00 |
| Revenue This Year | N/A | $16.82 |
| Revenue Next Year | N/A | $4.88 |
| P/E Ratio | ★ N/A | $12.61 |
| Revenue Growth | ★ 86.00 | 10.40 |
| 52 Week Low | $0.43 | $37.31 |
| 52 Week High | $77.00 | $46.92 |
Technical Indicators
Market Signals| Indicator | NKTR | NBTB |
|---|---|---|
| Relative Strength Index (RSI) | 61.90 | 49.12 |
| Support Level | $52.99 | $41.68 |
| Resistance Level | $75.96 | $42.65 |
| Average True Range (ATR) | 3.59 | 0.99 |
| MACD | -0.63 | 0.14 |
| Stochastic Oscillator | 88.37 | 74.48 |
Price Performance
Historical ComparisonAbout NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About NBTB NBT Bancorp Inc.
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.